Exploring the Booming Sanger Sequencing Service Market: Trends, Opportunities, and Challenges , Forecast Period (2022-20

Comments · 82 Views

Sanger sequencing is one of the oldest DNA sequencing methods which utilizes dideoxynucleotides to sequence DNA.

Sanger sequencing is one of the oldest DNA sequencing methods which utilizes dideoxynucleotides to sequence DNA. It is frequently used for the sequencing of plasmid DNA, polymerase chain reaction (PCR) products, and bacterial artificial chromosomes (BAC) and is the most preferred choice for mutation detection. The sanger sequencing service market is growing at a tremendous rate owing to its wide range of applications in the diagnosis of chronic diseases, unmet need for personalized medicine, and surge in the prevalence of rare genetic diseases.

Request Sample PDF here @ https://univdatos.com/report/sanger-sequencing-service-market/get-a-free-sample-form.php?product_id=36373

The Sanger sequencing service Market is expected to grow at a steady rate of around 10% during the forecast period (2022-2028). The sanger sequencing service market is primarily driven by the growing demand for genetic research and personalized medicine. Genetic research has become increasingly important in fields such as oncology, neurology, and infectious diseases, and sanger sequencing is often used in the initial stages of research projects to generate high-quality DNA sequences that can be analyzed for variations and mutations. In addition to genetic research, sanger sequencing is also used in clinical diagnostics to identify genetic mutations that can lead to diseases such as cancer, cystic fibrosis, and Huntington's disease.

According to UnivDatos Market Insights (UMI)’ research report “Global Sanger sequencing service Market”, the market is expected to witness robust growth during the forecast period (2022-2028) owing to the surge in the prevalence of various cancers and rising awareness regarding the diagnosis of cancer. The American Cancer Society Journal estimates that approximately 140,690 people in the U.S. are diagnosed with cancer each year and that 103,250 people pass away from cancer each year. In addition, the World Health Organization (WHO) cites cancer as the second leading cause of death worldwide. Moreover, the increase in the prevalence of rare genetic diseases and the surge in the demand for personalized medicine are also positively impacting the growth of the market. 

Based on application, the market is segmented into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and others. The biomarkers and cancer segment held the dominant share of the market in 2021 which is mainly due to the surge in the prevalence of cancer, high demand for advanced sanger systems and services for the identification of cancer biomarkers, and rising investment for ongoing cancer research. Apart from this, sanger sequencing can also be used in drug development to identify potential targets for cancer therapies. Moreover, strategic developments undertaken by market players are also anticipated to bolster the market's growth over the analysis period. For instance, in March 2022, Vela Diagnostics released new next-generation sequencing (NGS)-based panels to detect RNA and DNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue specimens. 

Ask for Customization @ https://univdatos.com/report/sanger-sequencing-service-market/get-a-free-sample-form.php?product_id=36373 

Based on end user, the market is segmented into academics and governmental organizations, pharmaceutical companies, hospitals & clinics, and others. The hospitals & clinics category held a significant share of the market in 2021. By using Sanger sequencing to identify specific genetic mutations and variants, hospitals and clinics can provide more personalized treatment plans for their patients. This has the potential to improve patient outcomes and reduce healthcare costs by reducing the need for trial-and-error treatments.

APAC to witness extensive growth

For a better understanding of the market adoption of the sanger sequencing service industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is expected to grow with significant CAGR during the forecast period. The growth of the APAC sanger sequencing service market is driven by various factors, including the increasing demand for genetic testing and personalized medicine, the growing prevalence of genetic disorders, and the rising focus on agriculture biotechnology. China is expected to dominate the market, owing to its large population and increasing demand for genetic testing. Japan is also a significant market, due to the presence of well-established research facilities and academic institutions.

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the sanger sequencing service market are Microsynth AG; Thermo Fisher Scientific, Inc.; Azenta Life Sciences; GenHunter Corporation; LGC Biosearch Technologies; Laragen, Inc; STARSEQ GmbH; Medisupport SA; Quintara; and ciGenom Labs Pvt. Ltd.

“Global Sanger sequencing service Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.    

Get more information , Please Visit us :  https://univdatos.com/report/sanger-sequencing-service-market/

Market Segmentation:

1.     By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others)

2.     By End User (Academics and Governmental Organizations, Pharmaceutical Companies, Hospitals & Clinics, and Others)

3.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

4.     By Company (Microsynth AG; Thermo Fisher Scientific, Inc.; Azenta Life Sciences; GenHunter Corporation; LGC Biosearch Technologies; Laragen, Inc; STARSEQ GmbH; Medisupport SA; Quintara; and ciGenom Labs Pvt. Ltd.)

5.     Key questions answered in the study:

1.     What are the current and future trends of the global sanger sequencing service industry?

2.     How the industry has been evolving in terms of the product, neoantigen type, application, and therapy type?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the global sanger sequencing service industry?

5.     What is the customer orientation, purchase behavior, and expectations from the global sanger sequencing service suppliers across various region and countries?

Comments